Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Relay Therapeutics, Inc. (RLAY) had Weighted-Average Shares Outstanding (Diluted) of 171.59M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$15.36M |
|
$-276.48M |
|
-- |
|
$15.36M |
|
$318.09M |
|
$-302.74M |
|
$26.26M |
|
$-276.48M |
|
$-276.48M |
|
$-276.48M |
|
$-276.48M |
|
$-276.48M |
|
$-276.48M |
|
$-302.74M |
|
$-301.83M |
|
171.59M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
171.59M |
$-1.61 |
|
$-1.61 |
|
| Balance Sheet Financials | |
$578.28M |
|
$1.73M |
|
$43.05M |
|
$621.33M |
|
$25.58M |
|
-- |
|
$28.69M |
|
$54.27M |
|
$567.06M |
|
$567.06M |
|
$567.06M |
|
173.87M |
|
| Cash Flow Statement Financials | |
$-235.46M |
|
$192.80M |
|
$1.60M |
|
$126.41M |
|
$85.35M |
|
$-41.05M |
|
$62.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1971.59% |
|
-1971.59% |
|
-1965.68% |
|
-1800.58% |
|
-1800.58% |
|
$-235.87M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-48.76% |
|
-48.76% |
|
-44.50% |
|
-48.76% |
|
$3.26 |
|
$-1.37 |
|
$-1.37 |
|